PARP inhibition in cancer therapyBRCA gene mutations in cancerDNA Repair Mechanisms

Mina Farag, Lindsay Alpert, A. Olivas, Shu-Yuan Xiao, Christopher Weber, Manik A. Amin, A. Shergill, C. Liao, L. Yassan, N. Setia

2026.3.1LABORATORY INVESTIGATION

DOI: 10.1016/j.labinv.2025.104921

Abstract

Abstract is not available.

Citation format

FARAG, Mina, et al. 634 γ-H2AX immunohistochemistry as a screening tool for BRCA-Mutated carcinomas and a potential indicator of PARP inhibitor resistance. LABORATORY INVESTIGATION, 2026, 106(3): 104921.